![]() AEON Biopharma AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology. | ![]() Cingulate Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety. | ![]() Belite Bio Belite Bio is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting eye diseases. | |||
Founding Date | Founding Date 2017 | Founding Date 2012 | Founding Date 2021 | Founding Date 2018 | Founding Date 2003 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Verona, IT HQ | Locations Irvine, US HQ Newport Beach, US | Locations Kansas City, US HQ Morristown, US | Locations San Diego, US HQ | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 383% decrease | Employees 6 | Employees 13 | Employees 12 | Employees 58 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 39.5 m | Valuation ($) 13.2 m | Valuation ($) 2.1 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($39.2m) (FY, 2025) | Net income ($22.4m) (FY, 2025) | Net income ($77.6m) (FY, 2025) | Net income (£14.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 22.5m | Total funding raised $ 112.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 66.8m |

AEON Biopharma (formerly Alphaeon and Priveterra Acquisition) is a clinical-stage biopharmaceutical company developing a botulinum toxin complex for debilitating medical conditions, with an initial focus on neurology and gastroenterology.
View company
Cingulate is a clinical-stage biopharmaceutical company that develops medications for patients with attention deficit hyperactivity disorder (ADHD) and anxiety.
View company
Belite Bio is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting eye diseases.
View company
e-therapeutics is a computational drug discovery company.
View company